Wings of Mercy MN, Coborn's Provide Medical Flight for Little Falls Woman

Monday, April 5, 2010 General News J E 4

ST. PAUL, MINN. -- A Little Falls, Minn., woman and her 30-month old daughter suffering from severe, disabling Lyme Disease, will board a mercy flight at St. Cloud Regional Airport Tuesday, April 6, for transport to New York, N.Y., for advanced, potentially life-saving medical care. The mercy flight is funded by Coborn's Incorporated of St. Cloud and coordinated by Wings of Mercy of Minnesota. Photographers and news media representatives are welcome to attend.

WHAT: Photo opportunity/media availability of local woman and child boarding a mercy medical flight for transport to New York, N.Y., for advanced, potentially life-saving treatment of late stage Lyme Disease.

WHO: Elizabeth Fading, 30, and her 30 month old daughter, Little Falls, suffer from late stage Lyme Disease that has ravaged their immune system, left them physically disabled and in financial need. They will travel to New York with family members. Coborn's pilots Kevin Welsh and Neil Meyers along with Wings Flight Director, Richard LaBute will be on hand as well. (Dan Coborn flew Wings 1st flight in January 1995). Coborn's Incorporated owns and operates 36 Coborn's Cash Wise Foods and grocery stores throughout the Upper Midwest, is funding the flight. Wings of Mercy is a 501 c 3 charity coordinating medical transportation to patients and families in medical and financial need throughout the Upper Midwest.

WHEN/WHERE: Noon, Tuesday, April 6, at the airport terminal of the St. Cloud Regional Airport, located 50 miles northwest of Minneapolis/St. Paul off U.S. Hwy. 10. The flight is scheduled for take-off at 12:30 p.m.

FOR DIRECTIONS OR MORE INFORMATION: Call 651-238-8920 or visit the Wings website at

Please Note: Due to space limitations in the aircraft, we will not be able to honor fly-along requests.

/PRNewswire -- April 5/

Contact: Kate Ritzer, Outreach Director 651-238-8920

SOURCE Wings of Mercy MN


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Peregrine Pharmaceuticals Reports Data From Newly ...
Senesco Technologies, Inc. Closes on Previously An...